首页> 外文会议>Controlled Release Society annual meeting >A New Miceller Anticancer Drug: In Vivo and In Vitro Evaluation of SMA-Pirarubicin Micelles
【24h】

A New Miceller Anticancer Drug: In Vivo and In Vitro Evaluation of SMA-Pirarubicin Micelles

机译:一种新的胶束抗癌药物:体内和体外评估SMA-吡咯比胶束

获取原文

摘要

A new miceller anticancer agent consisting of copolymer of styrene-maleic acid [SMA] and anthracycline as essential consistent is described. Among the anthracyclines, pirarubicin was found the most effective in specific activity and drug loading efficiency. In vivo antitumor effect was evaluated in various solid tumors.
机译:描述了一种新的胶束抗癌剂,由苯乙烯 - 马来酸[SMA]和蒽环类共聚物组成,作为必要的一致。在蒽环酰胺中,吡比蛋白在特定活性和药物负载效率中被发现是最有效的。在各种实体瘤中评估体内抗肿瘤效应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号